- Home
- Publications
- Publication Search
- Publication Details
Title
Landmarks in the treatment of muscle-invasive bladder cancer
Authors
Keywords
-
Journal
Nature Reviews Urology
Volume 14, Issue 9, Pages 565-574
Publisher
Springer Nature
Online
2017-07-04
DOI
10.1038/nrurol.2017.82
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
- (2017) J. Alfred Witjes et al. EUROPEAN UROLOGY
- Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
- (2017) Joaquim Bellmunt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomized phase III trial comparing adjuvant paclitaxel/gemcitabine/cisplatin (PGC) to observation in patients with resected invasive bladder cancer: Results of the Spanish Oncology Genitourinary Group (SOGUG) 99/01 study.
- (2017) L. G. Paz-Ares et al. JOURNAL OF CLINICAL ONCOLOGY
- Enhanced Recovery Pathways Versus Standard Care After Cystectomy: A Meta-analysis of the Effect on Perioperative Outcomes
- (2016) Mark D. Tyson et al. EUROPEAN UROLOGY
- A Single-centre Early Phase Randomised Controlled Three-arm Trial of Open, Robotic, and Laparoscopic Radical Cystectomy (CORAL)
- (2016) Muhammad Shamim Khan et al. EUROPEAN UROLOGY
- Guideline on Muscle-Invasive and Metastatic Bladder Cancer (European Association of Urology Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement
- (2016) Matthew I. Milowsky et al. JOURNAL OF CLINICAL ONCOLOGY
- Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
- (2016) Jonathan E Rosenberg et al. LANCET
- Contemporary evidence for robot-assisted radical cystectomy for treating bladder cancer
- (2016) Raj Satkunasivam et al. Nature Reviews Urology
- Clinical Validation of Chemotherapy Response BiomarkerERCC2in Muscle-Invasive Urothelial Bladder Carcinoma
- (2016) David Liu et al. JAMA Oncology
- The RAZOR (randomized open vs robotic cystectomy) trial: study design and trial update
- (2015) Norm D. Smith et al. BJU INTERNATIONAL
- Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: A Randomized Clinical Trial
- (2015) Bernard H. Bochner et al. EUROPEAN UROLOGY
- Systematic Review and Cumulative Analysis of Oncologic and Functional Outcomes After Robot-assisted Radical Cystectomy
- (2015) Bertram Yuh et al. EUROPEAN UROLOGY
- Towards effective adjuvant treatment for urothelial cancer
- (2015) Arlene O Siefker-Radtke et al. LANCET ONCOLOGY
- Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3–pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial
- (2015) Cora N Sternberg et al. LANCET ONCOLOGY
- MDR1 and ERCC1 Expression Predict Outcome of Patients with Locally Advanced Bladder Cancer Receiving Adjuvant Chemotherapy
- (2015) Andreas-Claudius Hoffmann et al. NEOPLASIA
- Critical Analysis of Bladder Sparing with Trimodal Therapy in Muscle-invasive Bladder Cancer: A Systematic Review
- (2014) Guillaume Ploussard et al. EUROPEAN UROLOGY
- The Impact of the Extent of Lymphadenectomy on Oncologic Outcomes in Patients Undergoing Radical Cystectomy for Bladder Cancer: A Systematic Review
- (2014) Harman M. Bruins et al. EUROPEAN UROLOGY
- MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
- (2014) Thomas Powles et al. NATURE
- Bladder preservation in the treatment of muscle-invasive bladder cancer (MIBC): a review of the literature and a practical approach to therapy
- (2013) Zachary L. Smith et al. BJU INTERNATIONAL
- Urinary diversion after radical cystectomy for bladder cancer: options, patient selection, and outcomes
- (2013) Richard K. Lee et al. BJU INTERNATIONAL
- Incidence, survival and mortality rates of stage-specific bladder cancer in United States: A trend analysis
- (2013) Firas Abdollah et al. Cancer Epidemiology
- Adjuvant Chemotherapy for Invasive Bladder Cancer: A 2013 Updated Systematic Review and Meta-Analysis of Randomized Trials
- (2013) Jeffrey J. Leow et al. EUROPEAN UROLOGY
- Expression of TIP60 (tat-interactive protein) and MRE11 (meiotic recombination 11 homolog) predict treatment-specific outcome of localised invasive bladder cancer
- (2012) Jens R. Laurberg et al. BJU INTERNATIONAL
- Use of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer Is Low Among Major European Centres: Results of a Feasibility Questionnaire
- (2012) Maximilian Burger et al. EUROPEAN UROLOGY
- Stage-specific impact of extended versus standard pelvic lymph node dissection in radical cystectomy
- (2012) Giuseppe Simone et al. INTERNATIONAL JOURNAL OF UROLOGY
- Surgical and Chemotherapeutic Management of Regional Lymph Nodes in Bladder Cancer
- (2012) Todd M. Morgan et al. JOURNAL OF UROLOGY
- Adjuvant chemotherapy with cisplatin and gemcitabine versus chemotherapy at relapse in patients with muscle-invasive bladder cancer submitted to radical cystectomy: an Italian, multicenter, randomized phase III trial
- (2011) F. Cognetti et al. ANNALS OF ONCOLOGY
- Phase III Study of Molecularly Targeted Adjuvant Therapy in Locally Advanced Urothelial Cancer of the Bladder Based on p53 Status
- (2011) Walter M. Stadler et al. JOURNAL OF CLINICAL ONCOLOGY
- International Phase III Trial Assessing Neoadjuvant Cisplatin, Methotrexate, and Vinblastine Chemotherapy for Muscle-Invasive Bladder Cancer: Long-Term Results of the BA06 30894 Trial
- (2011) JOURNAL OF CLINICAL ONCOLOGY
- Super Extended Versus Extended Pelvic Lymph Node Dissection in Patients Undergoing Radical Cystectomy for Bladder Cancer: A Comparative Study
- (2011) Pascal Zehnder et al. JOURNAL OF UROLOGY
- Surgery Illustrated - Surgical Atlas
- (2010) Richard E. Hautmann BJU INTERNATIONAL
- Mainz pouch continent cutaneous diversion
- (2010) Joachim W. Thüroff et al. BJU INTERNATIONAL
- Contemporary use of perioperative cisplatin-based chemotherapy in patients with muscle-invasive bladder cancer
- (2010) Ganesh V. Raj et al. CANCER
- MRE11 Expression Is Predictive of Cause-Specific Survival following Radical Radiotherapy for Muscle-Invasive Bladder Cancer
- (2010) A. Choudhury et al. CANCER RESEARCH
- Excision Repair Cross-Complementing Group 1 May Predict the Efficacy of Chemoradiation Therapy for Muscle-Invasive Bladder Cancer
- (2010) A. Kawashima et al. CLINICAL CANCER RESEARCH
- Treatment of Muscle Invasive Bladder Cancer: Evidence From the National Cancer Database, 2003 to 2007
- (2010) Ugo Fedeli et al. JOURNAL OF UROLOGY
- Molecular screening for bladder cancer: progress and potential
- (2010) Anirban P. Mitra et al. Nature Reviews Urology
- The Impact of Lymphadenectomy and Lymph Node Metastasis on the Outcomes of Radical Cystectomy for Bladder Cancer
- (2009) Alexander Karl et al. EUROPEAN UROLOGY
- Bladder cancer
- (2009) Donald S Kaufman et al. LANCET
- T-Cell Coregulatory Molecule Expression in Urothelial Cell Carcinoma: Clinicopathologic Correlations and Association with Survival
- (2008) S. A. Boorjian et al. CLINICAL CANCER RESEARCH
- Potential Impact of Postoperative Early Complications on the Timing of Adjuvant Chemotherapy in Patients Undergoing Radical Cystectomy: A High-Volume Tertiary Cancer Center Experience
- (2008) S. Machele Donat et al. EUROPEAN UROLOGY
- Defining Early Morbidity of Radical Cystectomy for Patients with Bladder Cancer Using a Standardized Reporting Methodology
- (2008) Ahmad Shabsigh et al. EUROPEAN UROLOGY
- Chemotherapy for muscle-invasive bladder cancer treated with definitive radiotherapy: persisting uncertainties
- (2008) Toni K Choueiri et al. Nature clinical practice. Oncology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started